Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Family Medicine
 Disease Category: Heart Failure
Location: United States, FL

Trial Information

Chronic Heart Failure

The study will evaluate the efficacy and safety of both aliskiren monotherapy and aliskiren/enalapril combination therapy as compared to enalapril monotherapy, on morbidity and mortality in patients with chronic heart failure NYHA Class II - IV.

Patient Inclusion Criteria:

  • 18 years and older
  • Patients with a diagnosis of chronic heart failure NYHA Class II-IV
  • LVEF < 35% at visit 1
  • Elevated BNP at visit 1
  • You must be treated with a ACE for at least 4 weeks prior to screening
  • Other protocol specific inclusion/exclusion criteria apply

If you qualify you will receive Investigational Product and study related medical care at no charge to you. Additionally you will be reimbursed for time and travel.

Patient Exclusion Criteria:

  • Please call Research Center for more details

If you qualify you will receive Investigational Product and study related medical care at no charge to you. You will also be compensated for time and travel.

Cardiology Research Associates
305 Memorial Medical Parkway Suite 301
Daytona Beach, FL 32117
Phone: 386-677-6672
Fax: (314) 972-9601

View Map

Research Center Information: Cardiology Research Associates

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.